紐威股份(603699.SH):增持計劃期滿 董祕衞瀚森累計增持8.5萬股
格隆匯 8 月 18日丨紐威股份(603699.SH)公佈,截至本公告日,公司董事會祕書衞瀚森增持公司股份計劃期限屆滿,增持計劃實施完成。衞瀚森通過上海證券交易所集中競價交易系統累計增持公司股份8.5萬股,佔公司總股本的0.0113%,累計增持金額約120.74萬元人民幣,累計增持金額已達本次增持計劃承諾金額的下限,本次增持計劃已實施完畢。本次增持計劃實施完成後,公司董事會祕書衞瀚森合計持有公司股份8.5萬股,佔公司總股本的0.0113%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.